Back to Results
First PageMeta Content
Amyotrophic lateral sclerosis / Health / Neuroscience / Prize4Life / James Heywood / ALS Therapy Development Institute / Rare diseases / Motor neurone disease


Media Contacts: Robert Goldstein, ALS TDI, [removed], [removed] Lisa McCormick, Aestus Therapeutics, [removed], [removed] EMBARGOED UNTIL FURTHER NOTICE – Tentative Release Date i
Add to Reading List

Document Date: 2010-06-14 10:48:03


Open Document

File Size: 20,60 KB

Share Result on Facebook

City

CAMBRIDGE / /

Company

Aestus Therapeutics Inc. / ALS TDI / /

Country

United States / /

/

Facility

ALS Therapy Development Institute / /

IndustryTerm

nonprofit biotechnology / biological data mining techniques / biotechnology organizations / /

MedicalCondition

progressive neurodegenerative disease / Lou Gehrig’s disease / schizophrenia / disease / chronic pain / ALS / novel disease / serious neurological diseases / Amyotrophic Lateral Sclerosis / ALS disease / diseases / /

Organization

ALS Therapy Development Institute / /

Person

Steve Perrin / Lou Gehrig / Tage Honore / Robert Goldstein / Lisa McCormick / /

/

Position

CEO & co-founder / CEO & chief scientific officer / /

ProvinceOrState

Massachusetts / /

Technology

proteomics / drug discovery / biotechnology / gene expression / data mining / drug development / /

URL

www.als.net / www.aestustherapeutics.com / /

SocialTag